Chugai Pharmaceutical (CHGCF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you very much for coming over to conference on financial results for the second quarter for the year ending in December 2025. I will be leading today's session. I am Miyata from Corporate Communications Ayo Departments. So today we have the participants of the venue as well as on the Zoom. And today's agenda is shown on a screen at the venue as well as on page 3 of the presentation materials. and today's conference will be conducted in japanese but we are also providing english on zoom webinar as a simultaneous interpretation please select the language that you wish to listen to please click the interpretation mark at the bottom of the screen and select either japanese or english And then you can also mute the original audio to listen to the language that you've chosen only. And before each presentation, we'll have time for the screen capture. So please make use of the time. And we'll take your questions after all the presentations are completed. We plan on spending for about half an hour for Q&A session. So feel free to ask your questions. And during the presentation, your sound will be unmuted. So now we want to pass the floor over to Ms. Okuda to talk about overview of the second quarter results. So we'll stop the screen for a while, so please use this time for screen capture. So now we would like to begin the presentation. I am Okuda, CEO of the company. I would like to explain about our financial result for the second quarter of 2025. Please take a look at page 5 of your handout. In the second quarter of 2025, domestic and overseas product sales increased, resulting in increased revenue and profit. Compared to the previous year, revenue increased by 4.6%, operating profit increased by 3.5%, and net income increased by 2.1%. Given the steady progress made i...